Tenaris S.A. (ADR) (TS): Are Hedge Funds Right About This Stock?

Page 1 of 2

Tenaris S.A. (ADR) (NYSE:TS) has experienced a decrease in hedge fund interest lately.

If you’d ask most stock holders, hedge funds are seen as worthless, old financial vehicles of years past. While there are over 8000 funds trading at the moment, we choose to focus on the bigwigs of this club, about 450 funds. Most estimates calculate that this group controls the lion’s share of all hedge funds’ total asset base, and by keeping an eye on their highest performing picks, we have discovered a number of investment strategies that have historically outperformed the broader indices. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have trumped the S&P 500 index by 24 percentage points in 7 months (see the details here).

Tenaris S.A. (ADR) (NYSE:TS)

Equally as beneficial, positive insider trading activity is another way to parse down the financial markets. Just as you’d expect, there are a variety of motivations for a corporate insider to downsize shares of his or her company, but only one, very obvious reason why they would buy. Plenty of empirical studies have demonstrated the market-beating potential of this method if “monkeys” know what to do (learn more here).

Now, it’s important to take a glance at the latest action encompassing Tenaris S.A. (ADR) (NYSE:TS).

What have hedge funds been doing with Tenaris S.A. (ADR) (NYSE:TS)?

In preparation for this year, a total of 6 of the hedge funds we track were long in this stock, a change of -14% from the third quarter. With the smart money’s capital changing hands, there exists a select group of notable hedge fund managers who were increasing their holdings significantly.

According to our comprehensive database, Jim Simons’s Renaissance Technologies had the largest position in Tenaris S.A. (ADR) (NYSE:TS), worth close to $25.2 million, comprising 0.1% of its total 13F portfolio. Coming in second is D E Shaw, managed by D. E. Shaw, which held a $9.4 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Some other hedgies that hold long positions include J. Alan Reid, Jr.’s Forward Management, Bruce Kovner’s Caxton Associates LP and Cliff Asness’s AQR Capital Management.

Since Tenaris S.A. (ADR) (NYSE:TS) has witnessed bearish sentiment from hedge fund managers, it’s easy to see that there was a specific group of fund managers that elected to cut their entire stakes heading into 2013. Intriguingly, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital dropped the largest position of the 450+ funds we watch, comprising an estimated $30.6 million in stock.. Israel Englander’s fund, Millennium Management, also cut its stock, about $0.7 million worth. These bearish behaviors are interesting, as total hedge fund interest fell by 1 funds heading into 2013.

What have insiders been doing with Tenaris S.A. (ADR) (NYSE:TS)?

Insider trading activity, especially when it’s bullish, is best served when the company in focus has experienced transactions within the past half-year. Over the last 180-day time period, Tenaris S.A. (ADR) (NYSE:TS) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Tenaris S.A. (ADR) (NYSE:TS). These stocks are Companhia Siderurgica Nacional (ADR) (NYSE:SID), Gerdau SA (ADR) (NYSE:GGB), Nucor Corporation (NYSE:NUE), ArcelorMittal (ADR) (NYSE:MT), and POSCO (ADR) (NYSE:PKX). This group of stocks belong to the steel & iron industry and their market caps resemble TS’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!